REVIEW
|
doi:10.20944/preprints202306.1898.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
chronic lymphocytic leukemia; older patient; ibrutinib; acalabrutinib; zanubrutinib; venetoclax; sustainabiity
Online: 27 June 2023 (12:04:57 CEST)
ARTICLE
|
doi:10.20944/preprints202311.1973.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
FLAMSA; allogeneic transplant (aHSCT); sequential conditioning; AML; MDS; myeloid malignancies; reduced-intensity conditioning; RIC; Venetoclax
Online: 30 November 2023 (10:24:31 CET)
ARTICLE
|
doi:10.20944/preprints202309.1417.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
R-RAS2; RAS; GTPases; chronic lymphocytic leukemia; B-CLL; mouse model; ibrutinib; venetoclax; new therapies; cancer treatment
Online: 21 September 2023 (12:04:56 CEST)
REVIEW
|
doi:10.20944/preprints202406.1677.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Genomic profiling; Targeted therapies; Hypomethylating agents; Venetoclax-based combinations; Intensive chemotherapy; Transplantation; Clinical trials; Supportive care; Quality of life
Online: 24 June 2024 (12:04:02 CEST)
CASE REPORT
|
doi:10.20944/preprints202406.1511.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
ibrutinib; 17p deletion; kidney biopsy; renal lymphomatous infiltration; monoclonal b cell lymphocytosis (mbl); complications of cll; venetoclax; chronic lymphocytic leukemia (cll); cll treatment; renal involvement in cll
Online: 24 June 2024 (07:41:28 CEST)